Soleno Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 05/04/2024
Soleno Therapeutics Stock Forecast and Price Target
The average price target for Soleno Therapeutics's stock of $51.00 recently provided by leading analysts would represent a 7.78% upside from its last closing price if reached. This potential increase is based on a high estimate of $59.00 and a low estimate of $44.00. If you are not interested in SLNO stock, you may still be interested in its competitors and their current standings.
7.78% Upside
Soleno Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
Soleno Therapeutics's Price has grown In the last zero years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $50.81 – an increase of 100.00%. For the next seven years, experts predict that Soleno Therapeutics's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$734.97 | Buy/Sell | $636.99 | 19.73% |
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$149.27 | Buy/Sell | $174.55 | 13.89% |
| MRK Stock Forecast | Merck | Outperform |
2
|
$127.51 | Buy/Sell | $130.51 | 12.15% |
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$27.81 | Buy/Sell | $32.87 | 9.67% |
| VRTX Stock Forecast | Vertex Pharmaceuticals Inc | Outperform |
12
|
$401.08 | Buy/Sell | $457.59 | 12.57% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| REGN Stock Forecast | Regeneron Pharmaceuticals | Outperform |
2
|
$957.00 | Buy/Sell | $961.26 | 9.72% |
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$43.99 | Buy/Sell | $58.15 | 22.76% |
| ZTS Stock Forecast | Zoetis | Outperform |
18
|
$167.07 | Buy/Sell | $220.47 | 34.08% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ALNY Stock Forecast | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$152.33 | Buy/Sell | $245.24 | 41.80% |
| BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$36.89 | Buy/Sell | $44.86 | 19.27% |
| VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.78 | Buy/Sell | $11.73 | 6.11% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| UTHR Stock Forecast | United Therapeutics | Outperform |
12
|
$262.40 | Buy/Sell | $284.08 | 14.33% |
| CTLT Stock Forecast | Catalent | Hold |
15
|
$56.50 | Buy/Sell | $49.29 | 12.39% |
| CYTK Stock Forecast | Cytokinetics | Outperform |
10
|
$65.27 | Buy/Sell | $87.92 | 44.02% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IONS Stock Forecast | Ionis Pharmaceuticals | Outperform |
9
|
$41.97 | Buy/Sell | $55.60 | 42.96% |
| BCPC Stock Forecast | Balchem | Outperform |
18
|
$150.40 | Buy/Sell | $145.00 | 8.38% |
| PRGO Stock Forecast | Perrigo Co PLC | Buy |
16
|
$32.79 | Buy/Sell | $44.75 | 21.99% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MDGL Stock Forecast | Madrigal Pharmaceuticals | Outperform |
4
|
$229.84 | Buy/Sell | $315.92 | 69.68% |
| NEOG Stock Forecast | Neogen | Outperform |
16
|
$12.02 | Buy/Sell | $37.00 | 41.43% |
| INDV Stock Forecast | Indivior PLC | Buy |
14
|
£14.35 | Buy/Sell | £28.89 | 115.54% |
Soleno Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
Soleno Therapeutics's EPS has grown In the last zero years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $-1.07 – an increase of 100.00%. For the next seven years, experts predict that Soleno Therapeutics's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CORT Stock Forecast | Corcept Therapeutics | Buy |
16
|
$24.52 | Buy/Sell | $35.67 | 63.13% |
| TGTX Stock Forecast | TG Therapeutics | Outperform |
9
|
$16.19 | Buy/Sell | $29.44 | 113.09% |
| AMPH Stock Forecast | Amphastar Pharmaceuticals | Outperform |
14
|
$42.46 | Buy/Sell | $69.00 | 46.02% |
.jpg)